Drug-drug Interaction Study of Digoxin and AT-527 (R07496998)

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 3, 2021

Primary Completion Date

December 12, 2021

Study Completion Date

December 12, 2021

Conditions
Healthy Volunteers Study
Interventions
DRUG

AT-527 + digoxin

"* Day 1: A single dose of digoxin will be administered.~* Day 15: A single dose of AT-527 and digoxin will be co-administered."

DRUG

AT-527 + digoxin

"* Day 1: A single dose of digoxin will be administered.~* Day 15: A single staggered dose of AT-527 and digoxin will be administered (2 hours later)."

Trial Locations (1)

Unknown

Atea Study Site, Montreal

Sponsors
All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

lead

Atea Pharmaceuticals, Inc.

INDUSTRY